EMA — authorised 20 September 2018
- Application: EMEA/H/C/004309
- Marketing authorisation holder: Portola Pharma UK Limited
- Local brand name: Dexxience
- Indication: Prevention of venous thromboembolism
- Status: rejected
🇪🇺 Bevyxxa in European Union
EMA authorised Bevyxxa on 20 September 2018
Marketing authorisation
Bevyxxa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Bevyxxa approved in European Union?
Yes. EMA authorised it on 20 September 2018.
Who is the marketing authorisation holder for Bevyxxa in European Union?
Portola Pharma UK Limited holds the EU marketing authorisation.